References
- Lichtman M. A. Agnogenic myeloid metaplasia. Hematology, W. J. Williams, E. Beutler, A. J. Erslev, M. A. Lichtman. McCraw-Hill, New York 1990; 223–232
- Bouroncle B. A., Doan C. A. Myelofibrosis, clinical hematologic and pathological study of 110 patients. Am. J. Med. Sci. 1962; 243: 697–715
- Cehrelli C., Ezdinli E. Z., Li C. Y., Krmpotic E. Blastic phase of agnogenic myeloid metaplasia simulating malignant lymphoma. Cancer 1976; 38: 1297–1305
- Rohenthal D. S., Moloney W. C. Occurrence of acute leukaemia in myelo-proliferative disorders. Br. J. Haematol. 1977; 36: 373–382
- Visani G., Finelli C., Castelli U., Petti M. C., Ricci P., Vianelli N., Gianni L., Zuffa E., Aloe Spiriti M. A., Latagliata R., Pileri S., Magrini U., Gugliotta L., Morra E., Bernasconi C., Mandelli F., Tura S. Myelofibrosis with myeloid metaplasia: clinical and haematological, parameter predicting survival in a series of 133 patients. Br J. Haematol. 1990; 75: 4–9
- Jacobs P., Le Roux I., Jacobs L. Megakaryoblastic transformation in myeloproliferative disorders. Cancer 1984; 54: 297–302
- Marcus R. E., Hibbin J. A., Matutes E., Whittle N., Waterfield M. D., Goldman J. M. Megakaryoblastic transformation of myelofibrosis with expression of the c-sis oncogene. Scand. J. Haematol. 1986; 36: 186–193
- Garcia S., Miguel A., Miguel A., Linares M., Navarro M., Colomina P. Idiopathic myelofibrosis terminating in erythroleukemia. Am. J. Hematol. 1989; 32: 70–71
- Kimura A., Fujimoto T., Inada T., et al. Blastic transformation inessential thrombocythemia. In vitro differentiation of blast cells into granulocytic, erythroid, and megakaryocytic lineages. Cancer 1990; 65: 1538–1544
- Minden M. D., Toyonaga B., Ha K., Yanagi Y., Chin B., Gelfand E., Mak T. Somatic rearrangement of T-cell antigen receptor gene in human T-cell malignancies. Proc. Natl. Acad. Sci. USA 1985; 82: 1224–1227
- Lefranc M. P., Rabbitts T. H. Two tandemly organized human genes encoding the T-cell γ constant-region sequences show multiple rearrangement in different T-cell type. Nature 1985; 316: 464–466
- Nakata Y. BCR-ABL mRNA expression in patients with chronic myeloproliferative disorders—Absence of BCR-ABL fused clone except chronic myelocytic leukemic—. Hiroshima J. Med. Sci. 1993; 42: 67–71
- Tesch H., Zankovich R., Fonatsch C., Diel V. Analysis of bcr rearrangements in primary thrombocythemia. Leuk. Res. 1990; 14: 241–246
- Vellenga E., Young D. C., Wagner K., Wiper D., Ostapovicz D., Griffin J. D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771–1776
- Kaufman D. C., Beer M. R., Gao X. Z., et al. Enhanced expression of the granulocyte-macrophage colony-stimulating factor gene in acute myelocytic leukemia cells following in vitro blast cell enrichment. Blood 1988; 72: 1329
- Miyauchi J., Kelleher C. A., Yang Y.-C., Wong G. G., Clark S. C., Minden M. D., Minkin S., McCulloch E. A. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood 1987; 70: 657–663
- Delwel R., Dorssars L., Touw T., et al. Human recombinant multilineage colony stimulating factor (Interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro. Blood 1987; 70: 333
- Budel L. M., Touw I. P., Delwel R., et al. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the pro-liferative response. Blood 1989; 74: 565–571
- Goselink H. M., Williams D. E., Fibbe W. E., Wessels H. W., Beverstock G. C., Willemze R., Falkenburg J. H. F. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells. Blood 1992; 80: 750–757